Home> Products> blood tests

{ "products": [ { "_id": "6891f29bfb7044dfb2d43adf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MAGRAL 160", "description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.", "price": 810.0, "discountamount": 243.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2156, "imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:01:31.195Z", "updatedon": "2025-08-05T12:01:31.195Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magral-160/2156", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "megestrol acetate 160 mg", "category": "Gynaecology", "tags": [ "megestrol acetate 160 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a4a65aea4ed7f1f8cd234b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Methotrexate (15mg)", "description": "METROTREX 15 contains Methotrexate 15mg, a potent medication used in the treatment of autoimmune diseases and certain types of cancer. As an antifolate drug, it inhibits cell division, making it effective for managing conditions like rheumatoid arthritis, psoriasis, and leukemia.\n\n \nKey Benefits of METROTREX 15:\n \n\nMETROTREX 15 provides several therapeutic benefits, including:\n\nTreatment of Rheumatoid Arthritis: Helps reduce joint inflammation and pain by suppressing immune responses.\n\nManagement of Psoriasis: Slows down excessive skin cell production, alleviating symptoms of psoriasis.\n\nCancer Therapy: Used in chemotherapy for conditions like leukemia, breast cancer, and lymphoma by inhibiting cancer cell growth.\n\nTreatment of Crohn’s Disease: Helps in managing severe cases of inflammatory bowel disease.\n\n \nHow Does METROTREX 15 Work?\n \n\nMethotrexate 15mg works by inhibiting dihydrofolate reductase (DHFR), an enzyme essential for DNA synthesis and cell division. By blocking this enzyme, METROTREX 15 prevents the rapid multiplication of abnormal cells, making it effective in autoimmune diseases and cancer treatment.\n\n \nDirections for Use of METROTREX 15:\n \n\nTo ensure the safe and effective use of METROTREX 15, follow these guidelines:\n\nTake METROTREX 15 exactly as prescribed by your doctor.\n\nIt is usually taken once a week for autoimmune conditions and as per the oncologist’s recommendation for cancer therapy.\n\nSwallow the tablet whole with water, preferably after meals to reduce stomach irritation.\n\nRegular monitoring of blood tests is necessary to assess the drug’s effects.\n\n \nSide Effects of METROTREX 15:\n \n\nWhile METROTREX 15 is effective, it may cause some side effects, including:\n\nCommon Side Effects:\n\nNausea and vomiting\n\nFatigue\n\nMouth ulcers\n\nHair loss\n\nDizziness\n\nSerious Side Effects:\n\nLiver toxicity\n\nKidney dysfunction\n\nSuppressed bone marrow function leading to low blood cell counts\n\nIncreased risk of infections\n\nLung inflammation\n\nSeek immediate medical attention if you experience severe side effects.", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "metrotrex 15", "metrotrex 15 follow", "autoimmune conditions", "medical attention", "side effects", "blood tests", "water preferably", "oncologists recommendation", "rapid multiplication", "cell division", "dna synthesis", "enzyme essential", "antifolate drug", "autoimmune diseases", "potent medication", "methotrexate 15mg", "methotrexate 15mgmetrotrex 15", "managing conditions", "therapeutic benefits", "psoriasis slows", "cancer treatment directions", "psoriasis cancer therapy", "managing severe cases", "leukemia key benefits", "cancer therapy swallow", "leukemia breast cancer", "rheumatoid arthritis psoriasis", "abnormal cells making", "inflammatory bowel disease", "crohns disease helps" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2051, "imageuri": "https://productimages.withfloats.com/actual/67a4a66d145c10370e023f04.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a4a66d145c10370e023f04.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-06T12:08:58.343Z", "updatedon": "2025-02-06T12:08:58.343Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/methotrexate-15mg-/2051", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METROTREX 15 ", "category": "", "tags": [ "Methotrexate 15 mg uses", "Methotrexate 15 mg Tablet price", "Methotrexate 15 mg Uses in Hindi", "Folitrax 15 mg tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6720bafc54731d7e7f9153bc", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Itraconazole (65 mg)", "description": "CONARIS SB 65 is a powerful antifungal medication specifically formulated to treat a variety of fungal infections. With its active ingredient, Itraconazole (65 mg), this medication is effective against both superficial and systemic fungal infections, providing comprehensive relief for individuals suffering from these conditions. Whether you're dealing with skin infections, nail infections, or more severe systemic issues, CONARIS SB 65 is designed to help restore your health and well-being.\n\n \nKey Benefits:\n \n\nBroad-Spectrum Antifungal Activity: CONARIS SB 65 effectively targets various fungi, including those responsible for conditions like athlete's foot, ringworm, and nail fungus.\n\nFast-Acting Formula: The formulation is designed to provide rapid relief from symptoms, helping to alleviate itching, redness, and discomfort associated with fungal infections.\n\nSystemic Treatment: In addition to treating superficial infections, Itraconazole can penetrate deep tissues, making CONARIS SB 65 suitable for systemic fungal infections.\n\nWell-Tolerated: Many patients tolerate CONARIS SB 65 well, with a low incidence of side effects, allowing for effective treatment without significant discomfort.\n\nConvenient Dosage Form: The formulation is easy to take, making it suitable for patients of all ages who require antifungal treatment.\n\n \nHow Does It Work?\n \n\nItraconazole works by inhibiting an enzyme called lanosterol 14-alpha demethylase, which is crucial for the conversion of lanosterol to ergosterol in fungal cell membranes. Ergosterol is essential for maintaining the integrity and fluidity of fungal cell membranes. By disrupting ergosterol synthesis, Itraconazole compromises the fungal cell membrane, leading to cell death and effectively clearing the infection. This mechanism makes CONARIS SB 65 an effective choice for treating both superficial and systemic fungal infections.\n\n \nDirections for Use:\n \n\nDosage: The recommended dosage of CONARIS SB 65 is one capsule (65 mg of Itraconazole) taken orally, once a day, or as directed by a healthcare professional.\n\nAdministration: It is advisable to take the capsule with a full glass of water, preferably after a meal to enhance absorption.\n\nDuration of Treatment: Treatment duration may vary depending on the type and severity of the infection. It is essential to complete the full course as prescribed, even if symptoms improve, to prevent recurrence.\n\nConsult Your Doctor: Always consult a healthcare professional for personalized dosing instructions based on your medical history and specific condition.\n\n \nSide Effects:\n \n\nWhile CONARIS SB 65 is generally well-tolerated, some individuals may experience side effects. Common side effects include:\n\nNausea: Mild stomach upset or nausea may occur, particularly when the medication is taken on an empty stomach.\n\nHeadache: Some users may report mild headaches during treatment.\n\nDizziness: Occasionally, patients may experience dizziness or lightheadedness.\n\nLiver Function: In rare cases, Itraconazole may affect liver function. Regular monitoring through blood tests may be necessary, especially in patients with pre-existing liver conditions.", "price": 148.0, "discountamount": 43.77, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "rare cases", "full glass", "CONARIS SB", "cell death", "one capsule", "blood tests", "full course", "nail fungus", "deep tissues", "rapid relief", "Key Benefits", "Many patients", "low incidence", "various fungi", "empty stomach", "Liver Function", "mild headaches", "medical history", "nail infections", "skin infections", "effective choice", "active ingredient", "Treatment duration", "Regular monitoring", "specific condition", "recommended dosage", "Systemic Treatment", "Mild stomach upset", "effective treatment", "Fast-Acting Formula", "Common side effects", "ergosterol synthesis", "comprehensive relief", "antifungal treatment", "fungal cell membranes", "significant discomfort", "superficial infections", "Convenient Dosage Form", "severe systemic issues", "healthcare professional", "existing liver conditions", "systemic fungal infections", "powerful antifungal medication", "personalized dosing instructions", "Broad-Spectrum Antifungal Activity" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2005, "imageuri": "https://productimages.withfloats.com/actual/6720bb028245cceadeafb927.png", "tileimageuri": "https://productimages.withfloats.com/tile/6720bb028245cceadeafb927.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-29T10:37:48.66Z", "updatedon": "2024-10-29T10:37:48.66Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/itraconazole-65-mg-/2005", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CONARIS SB 65 ", "category": "Dermatology", "tags": [ "Canditral SB 65 Uses in Hindi", "Itraconazole SB 65", "Itraconazole SB 65 Cipla" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d6df52731125bdd4e1003b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALGANCICLOVIR TABLET IP 450 MG", "description": "VOLANE SOURCE 450\nVALGANCICLOVIR TABLET IP 450 MG\nVOLANE SOURCE 450 contains Valganciclovir Tablet IP 450 mg, an antiviral medication used to treat infections caused by cytomegalovirus (CMV). CMV can affect various organs and is particularly dangerous in people with weakened immune systems, such as those who have undergone organ transplants or are living with HIV. Valganciclovir is essential for preventing CMV infections and managing existing ones.\n\n \nKey Benefits:\n \n\nPrevention of CMV Infections: VOLANE SOURCE 450 is primarily used to prevent CMV infections in high-risk individuals, especially those who have undergone organ transplants.\nTreatment of CMV Retinitis: It is also effective in treating CMV retinitis, a severe eye infection that can lead to blindness in people with weakened immune systems.\nHigh Oral Bioavailability: Valganciclovir offers a convenient oral option with high bioavailability, making it easier for patients to manage their treatment at home.\n \n\nHow Does It Work?\n\nValganciclovir, the active ingredient in VOLANE SOURCE 450, is converted into ganciclovir in the body. Ganciclovir works by inhibiting the replication of viral DNA. It incorporates into the viral DNA, leading to chain termination and preventing the virus from multiplying. This action helps control the spread of the CMV infection within the body, reducing symptoms and preventing further complications.\n\n \n\nDirections for Use:\n \n\nDosage: The dosage of VOLANE SOURCE 450 is determined by the healthcare provider based on the patient's medical condition, weight, and response to treatment.\nAdministration: The tablet should be taken orally with food to enhance absorption. Swallow the tablet whole without crushing or chewing.\nDuration: Follow the prescribed course of treatment, even if symptoms improve, to ensure the complete eradication of the virus.\n \n\nSide Effects:\n \n\nCommon Side Effects: Nausea, diarrhea, headache, and fatigue are some of the common side effects associated with Valganciclovir.\nSerious Side Effects: In rare cases, VOLANE SOURCE 450 may cause severe side effects such as bone marrow suppression, which can lead to conditions like anemia, leukopenia, and thrombocytopenia. Immediate medical attention is required if any signs of these conditions occur.\nMonitoring: Regular blood tests are recommended to monitor blood cell counts and kidney function during treatment with VOLANE SOURCE 450.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 4207.0, "discountamount": 1263.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "viral DNA", "rare cases", "Key Benefits", "CMV Retinitis", "VOLANE SOURCE", "CMV infection", "various organs", "kidney function", "prescribed course", "chain termination", "active ingredient", "organ transplants", "medical condition", "blood cell counts", "healthcare provider", "severe side effects", "Common Side Effects", "Regular blood tests", "complete eradication", "antiviral medication", "high bioavailability", "severe eye infection", "Serious Side Effects", "high-risk individuals", "convenient oral option", "bone marrow suppression", "weakened immune systems", "VALGANCICLOVIR TABLET IP", "High Oral Bioavailability", "Immediate medical attention" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1950, "imageuri": "https://productimages.withfloats.com/actual/66d6df583e7c26d6528cd0c0.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d6df583e7c26d6528cd0c0.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-03T10:05:06.943Z", "updatedon": "2024-09-03T10:05:06.943Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valganciclovir-tablet-ip-450-mg/1950", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VOLANE SOURCE 450", "category": "CARDIOLOGYRANGE", "tags": [ "VALGANCICLOVIR TABLET IP 450 MG USUE" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2024-07-10T13:01:05.875Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e77e853fc1c2298508399", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nTENELIGOLD PIO 20/15 combines two antidiabetic medications, Teneligliptin and Pioglitazone, in a single formulation. This combination is designed to manage type 2 diabetes mellitus by targeting different aspects of glucose metabolism, thereby improving glycemic control in patients who are inadequately controlled with monotherapy or require dual therapy.\n\nComposition\n\nTeneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon release, thereby lowering blood glucose levels.\nPioglitazone: A thiazolidinedione (TZD) that improves insulin sensitivity in peripheral tissues (muscle and adipose tissue) and reduces hepatic glucose production.\nMechanism of Action\n\nTeneligliptin: Inhibits the degradation of incretin hormones (GLP-1 and GIP), which play a key role in glucose-dependent insulin secretion and suppression of glucagon secretion.\nPioglitazone: Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), leading to improved insulin sensitivity, enhanced glucose uptake in peripheral tissues, and reduced hepatic glucose production.\nIndications\nTENELIGOLD PIO 20/15 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults who are inadequately controlled with diet and exercise alone or with other antidiabetic medications.\nDosage and Administration\n\nThe typical dosage is one tablet of TENELIGOLD PIO 20/15 taken orally once daily, preferably with meals.\nDosage adjustments may be necessary based on individual patient response and tolerability.\nIt is important to adhere to the prescribed dosage regimen to achieve optimal glycemic control.\nSide Effects\nCommon side effects may include:\n\nHypoglycemia (especially when used in combination with insulin or sulfonylureas)\nEdema (fluid retention)\nWeight gain\nHeadache\nNasopharyngitis (common cold)\nMore severe side effects can include:\n\nHeart failure (especially in patients with pre-existing cardiovascular disease)\nHepatic dysfunction (monitor liver function tests periodically)\nBone fractures (especially in women)\nPrecautions\n\nHeart Failure: Use with caution in patients with a history of heart failure or other cardiovascular diseases.\nBladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; therefore, it should be used cautiously in patients with a history of bladder cancer or with risk factors.\nLiver Function: Monitor liver function tests before starting treatment and periodically thereafter, as Pioglitazone may cause hepatic dysfunction.\nPregnancy and Lactation: Use during pregnancy and lactation should be avoided unless the potential benefits outweigh the risks.\nDrug Interactions\n\nInsulin/Sulfonylureas: Increased risk of hypoglycemia when used concomitantly with insulin or sulfonylureas.\nGemfibrozil: May increase Pioglitazone levels, requiring dose adjustment.\nCYP2C8 Inhibitors (e.g., Gemfibrozil): May increase Pioglitazone concentrations, necessitating monitoring for adverse effects.\nConclusion\nTENELIGOLD PIO 20/15 offers a dual-action approach to managing type 2 diabetes mellitus by combining Teneligliptin and Pioglitazone. This combination helps improve glycemic control through different mechanisms: enhancing insulin secretion and sensitivity. It is crucial to use this medication under the guidance of a healthcare professional to optimize treatment outcomes while minimizing the risk of side effects. Regular monitoring for efficacy and safety parameters, including blood glucose levels and potential adverse effects, is essential for managing diabetes effectively with TENELIGOLD PIO 20/15.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "one tablet", "Weight gain", "common cold", "risk factors", "dual therapy", "Heart failure", "increased risk", "dosage regimen", "typical dosage", "Bladder Cancer", "Bone fractures", "adipose tissue", "TENELIGOLD PIO", "glucose uptake", "dose adjustment", "fluid retention", "glucagon release", "DPP-4) inhibitor", "safety parameters", "CYP2C8 Inhibitors", "Drug Interactions", "incretin hormones", "different aspects", "Regular monitoring", "treatment outcomes", "Dosage adjustments", "peripheral tissues", "single formulation", "glucagon secretion", "potential benefits", "glucose metabolism", "insulin sensitivity", "Pioglitazone levels", "Hepatic dysfunction", "Common side effects", "different mechanisms", "dual-action approach", "liver function tests", "blood glucose levels", "dipeptidyl peptidase-4", "healthcare professional", "optimal glycemic control", "type 2 diabetes mellitus", "More severe side effects", "potential adverse effects", "hepatic glucose production", "Pioglitazone concentrations", "individual patient response", "two antidiabetic medications", "other cardiovascular diseases", "other antidiabetic medications", "existing cardiovascular disease", "glucose-dependent insulin secretion", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1935, "imageuri": "https://productimages.withfloats.com/actual/668e77ebf07c99c3af8e6d67.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e77ebf07c99c3af8e6d67.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:00:40.528Z", "updatedon": "2024-07-10T12:00:40.528Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-pio-20-15-/1935", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "teneligliptin + pioglitazone brand name", "Zita Plus Pio", "Teneligliptin + Pioglitazone Metformin", "Zita Piomet 1000", "Teneligliptin 20 MG and Pioglitazone 15 MG tablets", "Dapagliflozin", "Zita Piomet 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e72553345171da8e569d1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DIOWELPREX 250 ORAL SOLUTION ", "description": "DIOWELPREX 250 ORAL SOLUTION \nDivalproex (250mg/5ml)\nIntroduction\nDIOWELPREX 250 ORAL SOLUTION contains Divalproex (250mg/5ml), an anticonvulsant and mood-stabilizing medication used to treat various neurological and psychiatric conditions. It is particularly effective in managing epilepsy, bipolar disorder, and preventing migraine headaches.\n\nComposition\n\nDivalproex Sodium (250mg/5ml): A stable coordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship, providing a source of valproate ion which exhibits anticonvulsant and mood-stabilizing properties.\nMechanism of Action\nDivalproex works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, an inhibitory neurotransmitter that helps calm neuronal activity. It stabilizes electrical activity in the brain, reducing the frequency and severity of seizures, stabilizing mood in bipolar disorder, and preventing migraine headaches by altering the way nerves send signals.\n\nIndications\nDIOWELPREX 250 ORAL SOLUTION is indicated for:\n\nEpilepsy: Used to control various types of seizures including complex partial seizures and simple and complex absence seizures.\nBipolar Disorder: Helps in the management of manic episodes associated with bipolar disorder.\nMigraine Prophylaxis: Used to prevent migraine headaches.\nDosage and Administration\n\nEpilepsy: The initial dose is typically 10-15 mg/kg/day, gradually increased as needed and tolerated to achieve optimal clinical response.\nBipolar Disorder: The initial dose is generally 750 mg/day, given in divided doses, adjusted according to clinical response.\nMigraine Prophylaxis: The initial dose is usually 250 mg twice daily, adjusted as necessary.\nIt is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. The oral solution should be measured accurately using a dosing syringe or cup to ensure the correct dose is administered.\nSide Effects\nCommon side effects may include:\n\nNausea\nDrowsiness\nDizziness\nTremor\nHair loss\nWeight gain\nGastrointestinal disturbances\nMore severe side effects can include:\n\nLiver damage\nPancreatitis\nThrombocytopenia (low platelet count)\nHyperammonemia (high levels of ammonia in the blood)\nPrecautions\n\nLiver Function: Regular monitoring of liver function tests is recommended due to the risk of hepatotoxicity.\nPancreatitis: Patients should be monitored for signs of pancreatitis.\nPregnancy: Divalproex is associated with an increased risk of congenital malformations and should be used during pregnancy only if absolutely necessary and prescribed by a healthcare provider.\nBleeding Disorders: Caution is advised in patients with known bleeding disorders due to the risk of thrombocytopenia.\nDrug Interactions\n\nAntiepileptic Drugs: Concurrent use with other antiepileptic drugs may require dosage adjustments.\nWarfarin: May enhance the anticoagulant effect, necessitating close monitoring of INR levels.\nTopiramate: Co-administration can lead to hyperammonemia and encephalopathy.\nAlcohol: Should be avoided as it can exacerbate the side effects of Divalproex and further impair mental and motor skills.\nConclusion\nDIOWELPREX 250 ORAL SOLUTION is an effective medication for managing epilepsy, bipolar disorder, and preventing migraines. With its active ingredient Divalproex, it helps stabilize neuronal activity and mood. Proper dosage and administration under the guidance of a healthcare professional are essential to maximize benefits and minimize potential side effects. Regular monitoring and adherence to medical advice ensure the safe and effective use of DIOWELPREX 250 ORAL SOLUTION.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 445.0, "discountamount": 133.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "250 mg", "750 mg", "10-15 mg", "Hair loss", "INR levels", "high levels", "Weight gain", "motor skills", "correct dose", "initial dose", "Liver damage", "Proper dosage", "effective use", "divided doses", "various types", "valproate ion", "valproic acid", "increased risk", "medical advice", "Concurrent use", "dosing syringe", "manic episodes", "close monitoring", "sodium valproate", "bipolar disorder", "Divalproex Sodium", "active ingredient", "Drug Interactions", "neuronal activity", "dosage adjustments", "Bleeding Disorders", "Regular monitoring", "migraine headaches", "low platelet count", "healthcare provider", "electrical activity", "Common side effects", "effective medication", "anticoagulant effect", "Migraine Prophylaxis", "various neurological", "liver function tests", "1:1 molar relationship", "psychiatric conditions", "potential side effects", "healthcare professional", "gamma-aminobutyric acid", "congenital malformations", "complex absence seizures", "complex partial seizures", "More severe side effects", "other antiepileptic drugs", "optimal clinical response", "administration instructions", "inhibitory neurotransmitter", "mood-stabilizing properties", "mood-stabilizing medication", "DIOWELPREX 250 ORAL SOLUTION", "stable coordination compound", "Gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1933, "imageuri": "https://productimages.withfloats.com/actual/668e72573a68154e11e7951b.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e72573a68154e11e7951b.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:36:53.173Z", "updatedon": "2024-07-10T11:36:53.173Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/diowelprex-250-oral-solution-/1933", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DIOWELPREX 250 ORAL SOLUTION ", "category": "NEUROLOGY RANGE", "tags": [ "Divalproex 250 mg", "Divalproex side effects", "Divalproex prolonged release tablets", "Divalproex extended release tablets IP 250 mg", "Divalproex prolonged release tablets uses", "Divalproex 250 mg side effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ac1c8d0d0330684bdbc69", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 4 ", "description": "NICOMALOM 4 \nNicoumalone (4mg)\nIntroduction:\n\nNICOMALOM 4 contains Nicoumalone (4 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 4 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 4 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-4-133593", "price": 389.4, "discountamount": 116.82, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "4 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1862, "imageuri": "https://productimages.withfloats.com/actual/667d22cdba7e6420d2a5125f.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d22cdba7e6420d2a5125f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:54:16.529Z", "updatedon": "2024-06-27T08:29:00.414Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-4-/1862", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 4 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 4 mg tablet price", "nicoumalone 4mg", "nicoumalone 1mg uses in hindi", "acitrom 4mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abf93396cee0250f91bbf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 3 ", "description": "NICOMALOM 3 \nNicoumalone (3mg)\nIntroduction:\n\nNICOMALOM 3 contains Nicoumalone (3 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 3 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 3 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-3-133592", "price": 359.4, "discountamount": 107.82, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "EMAIL", "water", "Doses", "heart", "tablet", "product", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "3 mg dosage", "information", "INR) levels", "Nicoumalone", "initial dose", "sterisonline", "Key Features", "sterispharma", "Introduction", "CALL/WHATSAPP", "long-term use", "Initial Dosage", "Administration", "prothrombin time", "most indications", "target INR range", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1861, "imageuri": "https://productimages.withfloats.com/actual/666abf968b71a2cb2d7d4e2d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666abf968b71a2cb2d7d4e2d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:44:51.78Z", "updatedon": "2024-06-26T11:15:50.58Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-3-/1861", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 3 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 3mg uses", "nicoumalone side effects", "nicoumalone tablet uses in hindi", "nicoumalone contraindications", "nicoumalone tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }